Australia markets closed

Nautilus Biotechnology, Inc. (NAUT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3400+0.0600 (+2.63%)
At close: 04:00PM EDT
2.3399 -0.00 (-0.00%)
After hours: 04:05PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
19,397
114,523
185,619
36,607
Other short-term investments
154,021
69,948
160,110
40,135
Total cash
173,418
184,471
345,729
76,742
Other current assets
3,419
2,738
3,493
917
Total current assets
176,837
187,209
349,222
77,659
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
41,535
35,529
33,854
7,498
Accumulated depreciation
-4,634
-2,963
-1,994
-1,285
Net property, plant and equipment
36,901
32,566
31,860
6,213
Equity and other investments
90,647
129,169
16,371
0
Other long-term assets
1,180
1,108
842
612
Total non-current assets
128,728
162,843
49,228
7,352
Total assets
305,565
350,052
398,450
85,011
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,639
1,272
1,723
470
Accrued liabilities
976
1,421
1,266
452
Other current liabilities
379
438
388
133
Total current liabilities
9,122
6,791
5,812
3,018
Non-current liabilities
Total non-current liabilities
31,090
28,337
29,062
111,714
Total liabilities
40,212
35,128
34,874
114,732
Stockholders' equity
Common stock
13
12
12
1
Retained earnings
-202,239
-138,564
-80,640
-30,325
Accumulated other comprehensive income
-255
-1,854
-184
3
Total stockholders' equity
265,353
314,924
363,576
-29,721
Total liabilities and stockholders' equity
305,565
350,052
398,450
85,011